Privia Health Group, Inc.

NasdaqGS:PRVA Stock Report

Market Cap: US$2.1b

Privia Health Group Future Growth

Future criteria checks 4/6

Privia Health Group is forecast to grow earnings and revenue by 26.4% and 10% per annum respectively. EPS is expected to grow by 23% per annum. Return on equity is forecast to be 6% in 3 years.

Key information

26.4%

Earnings growth rate

23.0%

EPS growth rate

Healthcare earnings growth15.8%
Revenue growth rate10.0%
Future return on equity6.0%
Analyst coverage

Good

Last updated09 Apr 2024

Recent future growth updates

Recent updates

Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

Mar 03
Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

Feb 27
The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Jan 31
There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Dec 03
Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Nov 06
Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Aug 08
Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Mar 17
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Privia Health: In Line For Solid FY22, Hold On Valuation

Sep 15

Privia Health Group reports Q2 earnings beat; raises FY22 outlook

Aug 11

Privia Health Group Grows But Operating Results Await

Jun 20

Is Privia Health Group, Inc. (NASDAQ:PRVA) Trading At A 48% Discount?

Feb 09
Is Privia Health Group, Inc. (NASDAQ:PRVA) Trading At A 48% Discount?

Privia Health Group: Not Healthy Yet

Feb 06

A Look At The Fair Value Of Privia Health Group, Inc. (NASDAQ:PRVA)

Nov 11
A Look At The Fair Value Of Privia Health Group, Inc. (NASDAQ:PRVA)

Calculating The Intrinsic Value Of Privia Health Group, Inc. (NASDAQ:PRVA)

Jul 29
Calculating The Intrinsic Value Of Privia Health Group, Inc. (NASDAQ:PRVA)

Privia Health Group, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 28

Disrupting Healthcare - IPO Interview With Privia Health CEO Shawn Morris (Video)

May 03

Privia Health Group: Good Intentions Do Not Automatically Make A Good Investment

May 01

Earnings and Revenue Growth Forecasts

NasdaqGS:PRVA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,153551181266
12/31/20251,87542929315
12/31/20241,66130767616
12/31/20231,658238181N/A
9/30/20231,581384646N/A
6/30/20231,507343940N/A
3/31/20231,429163939N/A
12/31/20221,357-94747N/A
9/30/20221,268-3856N/A
6/30/20221,176-495252N/A
3/31/20221,066-2115252N/A
12/31/2021966-1885555N/A
9/30/2021905-1726464N/A
6/30/2021860-1473737N/A
3/31/2021818314343N/A
12/31/2020817313939N/A
12/31/201978681924N/A
12/31/2018658-355N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PRVA's forecast earnings growth (26.4% per year) is above the savings rate (2.3%).

Earnings vs Market: PRVA's earnings (26.4% per year) are forecast to grow faster than the US market (14.3% per year).

High Growth Earnings: PRVA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PRVA's revenue (10% per year) is forecast to grow faster than the US market (8% per year).

High Growth Revenue: PRVA's revenue (10% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PRVA's Return on Equity is forecast to be low in 3 years time (6%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.